Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
NB: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year (FY) 2023 Concepts
- NIAID Vaccine Adjuvant Development Program in Infectious and Immune-Mediated Diseases
- Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival
FY 2023 Small Business Innovation Research (SBIR) Contract Solicitation Topics
- Adjuvant Development for Vaccines for Infectious and Immune-Mediated Diseases
- Adjuvant Discovery for Vaccines for Infectious and Immune-Mediated Diseases
- Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models
NIAID Vaccine Adjuvant Development Program in Infectious and Immune-Mediated Diseases
For the published broad agency announcement, check the April 13, 2022, solicitation NIAID Vaccine Adjuvant Development Program in Infectious and Immune-Mediated Diseases.
Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival
For the published notice of special interest, check the February 23, 2022 Guide notice, Notice of Special Interest (NOSI)—Optimizing Vascularized Composite Allograft Survival.
Adjuvant Development for Vaccines for Infectious and Immune-Mediated Diseases
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Adjuvant Discovery for Vaccines for Infectious and Immune-Mediated Diseases
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.
Reagents for Immunologic Analysis of Non-Mammalian and Underrepresented Mammalian Models
For the published request for proposals, check the August 8, 2022 solicitation, A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proposals.